Article info
PDFReview
Autoantibody testing in idiopathic inflammatory myopathies
- Correspondence to Dr Anke Rietveld, Department of Neurology, Center for Neuroscience Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen 6500 HB, The Netherlands; Anke.Rietveld{at}radboudumc.nl
Citation
Autoantibody testing in idiopathic inflammatory myopathies
Publication history
- Received March 2, 2018
- Revised December 13, 2018
- Accepted January 22, 2019
- First published March 2, 2019.
Online issue publication
July 11, 2019
Article Versions
- Previous version (2 March 2019).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.
Other content recommended for you
- Machine learning algorithms reveal unique gene expression profiles in muscle biopsies from patients with different types of myositis
- MRI of skeletal muscles in patients with idiopathic inflammatory myopathies: characteristic findings and diagnostic performance in dermatomyositis
- Anti-Ro52 autoantibodies are associated with interstitial lung disease and more severe disease in patients with juvenile myositis
- Evaluation and treatment of inflammatory myopathies
- Focused HLA analysis in Caucasians with myositis identifies significant associations with autoantibody subgroups
- Increased serum levels of B cell activating factor (BAFF) in subsets of patients with idiopathic inflammatory myopathies
- Autoantibody profiles in the sera of European patients with myositis
- The EuroMyositis registry: an international collaborative tool to facilitate myositis research
- Clinical features and prognosis in anti-SRP and anti-HMGCR necrotising myopathy
- DIAGNOSIS AND TREATMENT OF INFLAMMATORY MUSCLE DISEASES